Transcription-targeted gene therapy for androgen-independent prostate cancer
Open Access
- 22 April 2002
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (5) , 443-452
- https://doi.org/10.1038/sj.cgt.7700451
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A Tissue-Specific Enhancer of the Prostate-Specific Membrane Antigen Gene, FOLH1Genomics, 2001
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Establishment of Parameters for Optimal Transduction Efficiency and Antitumor Effects with Purified High-Titer HSV-TK Retroviral Vector in Established Solid TumorsHuman Gene Therapy, 1997
- Defining a Functional Androgen Responsive Element in the 5′ Far Upstream Flanking Region of the Prostate-Specific Antigen GeneBiochemical and Biophysical Research Communications, 1997
- Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancerInternational Journal of Cancer, 1997
- Stereoselective Synthesis of 6-Methyl-9-(2-Deoxy-β-D-Erythro-Pentofuranosyl)purineNucleosides and Nucleotides, 1996
- Suramin-Induced Decrease in Prostate-Specific Antigen Expression With No Effect on Tumor Growth in the LNCaP Model of Human Prostate CancerJNCI Journal of the National Cancer Institute, 1996
- Prostate-specific Antigen Expression Is Regulated by an Upstream EnhancerJournal of Biological Chemistry, 1996
- Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer ModelsHuman Gene Therapy, 1996
- In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-FluorocytosineHuman Gene Therapy, 1995